share_log

研报掘金丨国海证券:维持美年健康“买入”评级,中长期看好公司预防医学平台价值

Research Report Nuggets: Guohai Securities: Maintaining the “buy” rating of American Health, optimistic about the value of the company's preventive medicine platform in the medium to long term

Gelonghui Finance ·  Dec 8, 2023 15:19
Gelonghui, December 8 | Guohai Securities Research Report points out that American Health (002044.SZ) has launched a stock options incentive plan, making concerted efforts to create a new American year. The incentive plan is conducive to fully mobilizing the enthusiasm of the company's directors, executives, middle level cadres and core cadres, ensuring the achievement of the company's development strategy and business goals, and effectively combining the interests of shareholders, the company, and the interests of the core team. The company is a leader in private health examinations in China. Since this year, it has entered a benign development channel driven by demand and rising volume and price. It is optimistic about the value of the company's preventive medicine platform in the medium to long term. Maintain a “buy” rating.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment